Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Clinical Review entitled “Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and Asthma: A Systematic Review,” published in the March 27, 2013, issue of JAMA (2013;309:1278-1288. doi:10.1001/jama.2013.2049), a clarification should be made in 2 places. On page 1281, under the heading “Rhinitis,” the third sentence should read “The majority of studies (94%) demonstrated greater improvement in the sublingual immunotherapy groups vs placebo.” In Table 1, second row, “Rhinitis or rhinoconjunctivitis symptoms scores,” in column 7, “Findings,” should read “The majority of studies showed greater improvement in symptoms in the sublingual immunotherapy group vs placebo.” This article has been corrected online.
Clarification of Data. JAMA. 2013;310(6):647. doi:10.1001/jama.2013.48989
Browse and subscribe to JAMA Network podcasts!
Create a personal account or sign in to: